Merck & Co., Inc.

Insider Reports History

Entity
Company
Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Kelly E.W. Grez, Kelly E.W. Grez, Corporate Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Merck & Co., Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Harpoon Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.0001 1K $23K $23.00 Mar 11, 2024 Indirect
Organon & Co. 10%+ Owner Common Stock 0 $21.53 Jun 2, 2021 Direct

Insider Reports Filed by Merck & Co., Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HARP Harpoon Therapeutics, Inc. Mar 11, 2024 1 $492M 4 Mar 11, 2024 10%+ Owner
HARP Harpoon Therapeutics, Inc. Jan 7, 2024 0 $0 3 Jan 17, 2024 10%+ Owner
OGN Organon & Co. Jun 2, 2021 1 $0 4 Jun 4, 2021 10%+ Owner
OGN Organon & Co. May 7, 2021 0 $0 3 May 7, 2021 10%+ Owner